RecruitingNCT05231655
Ex VIvo DEtermiNed Cancer Therapy
Studying Melanoma of soft tissue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Principal Investigator
- Sarah Danson, PhD, FRCPUniversity of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust
- Intervention
- Functional drug screen(diagnostic_test)
- Enrollment
- 600 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2021 – 2027
Study locations (1)
- Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom
Collaborators
University of Sheffield
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05231655 on ClinicalTrials.govOther trials for Melanoma of soft tissue
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06942143An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid TumorsGuangzhou FineImmune Biotechnology Co., LTD.
- RECRUITINGPHASE1NCT06889766NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and SarcomaCentre Hospitalier Universitaire Vaudois
- ACTIVE NOT RECRUITINGNANCT05121545Proton Pencil Beam Scanning GRID for Treatment of Bulky TumorsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins